Managing Insulin With a Voice AI
Trial ID or NCT#
This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.
Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial
- - Patients with Type 2 Diabetes - Patients clinically indicated to be taking daily long-acting insulin - Patients currently taking long-acting insulin but necessitating active dose adjustments
- - Patients who do not speak English - Patients who do not own a smart phone - Patients who do not have stable wireless internet connection at home
Contact us to find out if this trial is right for you.